UK and Swedish researchers have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of biopharmaceutical products, making the process both safer and less costly.
bioMerieux hopes that its new specially-packaged growth media products will help it “clean up” in the pharmaceutical industry’s lucrative sterility testing market
UK-based polymer technology specialist Chromatide and Akzo Nobel's Separation Products (SP) unit are teaming to develop a HPLC media for purification applications in the drug manufacturing industry.
Canada’s PharmEng International almost tripled its turnover in the second quarter, as its acquisition of a Pfizer manufacturing facility at the end of 2007 transformed sales at contract manufacturing facility Keata Pharma.
Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.
Oxford Diffraction has launched a new dual wavelength X-ray diffractometer that promises to determine the structure of molecules in even the most challenging of crystal samples.
Hungarian researchers have developed a new bioinformatics tool that can identify and correct abnormal, incorrect and mispredicted protein annotations in public databases.
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
Exclusive interview with Bilcare CSO Dr Praful Naik
Executives in pharmaceutical companies tasked with implementing an anti-counterfeiting strategy already have a difficult job assessing a frankly bewildering array of technological solutions.
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.
India’s Dishman Pharmaceuticals is eyeing up the lucrative oncology market to further its development as one of the region's major CRAM firms, according to company managing director Rajnikant Vyas.
A new study by US contract services giant Parexel International reveals that the number of marketing applications for NMEs in the US grew 33 per cent in 2007.
Sancilio & Co (SCI) says that its new contract manufacturing plant in Riviera Beach, Florida can provide pharmaceutical manufacturers with small batch production capacity for drug tablets and capsules.
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.
US researchers have developed a new technique that has enabled them to determine the structure of membrane proteins without having to first crystallise the samples.
Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.
Sweden’s Recipharm hopes that its newly acquired lyophilisation plant will complete its contract services offering and firmly establish it as a player on the CDMO stage.
Advalytix’ AmpliGrid technology is playing a key role in enabling researchers to discover how just a single cell can lay a huge role in complex biological systems.
Researchers have used Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) arrays to discover genetic variations that increase the risk of schizophrenia.
Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.
San Antonio-headquartered manufacturing firm DPT Laboratories has won a long-term contract to produce stocks of CPEX Pharmaceuticals’ candidate intranasal insulin product Nasulin for clinical trials.
Australia’s CSL Ltd has signed a $3.1bn agreement to acquire Talecris Biotherapeutics of the US and throw down the gauntlet to rival Baxter International in the plasma-based pharmaceutical sector.
Venus Remedies’ oncology facility has received EMEA GMP accreditation, making it one of very few Indian contract manufacturers licensed to make cancer treatments for the European market.
Pharmaceutical company Enzon may hive off its entire specialty drugs division, including a manufacturing facility in Indianapolis, US, in the face of pressure from shareholder Carl Icahn.
Cambrex posted a 5 per cent hike in revenues in the second quarter, helped by its shift into contract controlled substance manufacture, although without favourable currency effects sales would have slipped back 2.6 per cent.
University of York, UK, spin-out Paraytec, has published new results that extend the use of its ActiPix UV area imaging detector to applications in enzyme assays and protein sizing.
Integrated DNA Technologies (IDT) has completed the expansion of its European production facility, enabling the company to supply its European customers faster than ever before.
Bruker recorded a 31 per cent increase in revenue for the second quarter, marking a strong start after it acquired its affiliated Bruker BioSpin in February for $914m.
Veeco Instruments returned to profitability with the company’s ‘best quarterly performance in two years’ even though its metrology unit struggled due to weakness in the semiconductor market.
TTP LabTech has launched the RAPid 4 - a flow-based biosensor that can conduct real-time label-free molecular interaction analysis in buffered solutions and in complex biological mixtures.
US packaging specialist West Pharmaceutical Services has carried the earnings momentum it generated in the first three months of the year through to the second quarter.
Generic drugmaker Actavis Totowa has voluntarily recalled all drugs produced at its Little Falls, New Jersey manufacturing facility after an FDA inspection uncovered several breaches of current GMP codes.
Lonza hopes that the new business it has set up in China will help cement its position as a leading provider of services to the country’s pharmaceutical manufacturing sector.
Harro Hofliger’s adoption of the FMEA-Med software will help the German machining specialist minimize risk during development operations, according to Canadian developer Dyadem.
Combined CMO and specialty pharmaceutical group Akorn hopes that deals signed this month with Bioniche Pharma and an as yet unidentified drugmaker will help its manufacturing division make up the ground lost in the last quarter.
Invitrogen’s plans to buy Applied Biosystems (ABI) are on track with US antitrust regulators approving the deal and both firms achieving strong revenue growth.
Affymetrix slumped to an operating loss in the second quarter of 2008, reporting flat revenues and blaming a 30 per cent reduction in sales to the pharmaceutical sector.
Robert Friel’s tenure as CEO of PerkinElmer continued its strong start with the firm reporting a 21 per cent increase in second quarter revenues compared to the same period last year.
US Senator Sherrod Brown has fired off another broadside in his probe into pharmaceutical outsourcing, this time sending a request to Merck & Co “for further information on its heavy reliance on global outsourcing for the manufacture of pharmaceutical...
In response to high customer demand, leading automated chemistry systems manufacturer Syrris is now offering to build custom-made laboratory reactor systems designed to meet individual customer needs.
Bio-Rad has published several application notes describing the use of its Profinity eXact protein expression system to obtain tag-free native proteins from a cell lysate in less than an hour.
Contract manufacturer Nectar Lifesciences is to invest around RS 6bn ($141m) in a new bulk drug and pharmaceutical intermediate manufacturing facility in India's northern Punjab state.
R&D integration specialist Symyx Technologies says its Powdernium Workstation is integral to the new automated dry powder dispensing system developed by a "major" but as yet unidentified pharmaceutical company.
UK researchers have used the ReNcell VM stem cell line, licensed by Millipore from UK stem cell therapy experts ReNeuron, to model neural degeneration observed in Parkinson's disease.
Thermo Fisher Scientific has followed up its acquisition of Open Biosystems with the purchase of antibody experts Affinity BioReagents to further bolster its protein research offering.
US physicists have built the world's most sensitive 'nanomechanical mass spectrometer' that can accurately determine the mass of objects lighter than a single gold atom.
